Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Case Series
Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,242 | Dovepress* | 8,945+ | 1,912 | 10,857 | |
| PubMed Central* | 1,297 | 665 | 1,962 | ||
| Totals | 10,242 | 2,577 | 12,819 | ||
| *Since 18 January 2017 | |||||
View citations on PubMed Central and Google Scholar